NEW YORK, Jan. 21 (GenomeWeb News) - The board of directors of Applera declared today a regular quarterly dividend of $.0425 per share on Appera-Applied Biosystem Group Common Stock. The dividend is payable on April 1 to stockholders of record as of the close of the business March 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.